insulins - CISMeF

Preferred Label : insulins;

MeSH definition : Peptide hormones that cause an increase in the absorption of GLUCOSE by cells within organs such as LIVER, MUSCLE and ADIPOSE TISSUE. During normal metabolism insulins are produced by the PANCREATIC BETA CELLS in response to increased GLUCOSE. Natural and chemically-modified forms of insulin are also used in the treatment of GLUCOSE METABOLISM DISORDERS such as DIABETES MELLITUS.; Peptide hormones that cause an increase in the absorption of GLUCOSE by cells within organs such as LIVER; MUSCLE and ADIPOSE TISSUE. During normal metabolism insulins are produced by the PANCREATIC BETA CELLS in response to increased GLUCOSE. Natural and chemically-modified forms of insulin are also used in the treatment of GLUCOSE METABOLISM DISORDERS such as DIABETES MELLITUS.;

Wikipedia automatic translation : Insulin;

MeSH annotation : general or unspecified; prefer specifics;

Wikipedia link : https://en.wikipedia.org/wiki/Insulin;

Codes EINECS : 232-672-8;

Is substance : O;

Details

Origin ID

D061385;

UMLS CUI

C3537244;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Bound insulin (substance) [SNOMED CT concept]
- Hyperinsulinaemia [MedDRA Preferred Term]
- Infantile nystagmus syndrome (disorder) [SNOMED CT concept]
- Insular structure (body structure) [SNOMED CT concept]
- Insulin [OMIM gene]
- Insulin (amorphous) (globin) (isophane) (Lente) (NPH) (Semilente) (Ultralente) [ICD-11 Extension code]
- Insulin Measurement [NCIt concept]
- Insulin Resistance Measurement [NCIt concept]
- Insulin Sensitivity Measurement [NCIt concept]
- Insulin high [MedDRA LLT]
- Insulin regular [LOINC component]
- Insulin type [LOINC component]
- Insulin used (attribute) [SNOMED CT concept]
- diabetes medicines [MedlinePlus Topic]
- insulin [HGNC gene]
- insulin [LOINC Challenge]
- insulin [medical devices type]
CISMeF manual mappings
- Insulin adverse reaction (disorder) [SNOMED CT concept]
Record concept(s)
- insulins [MeSH concept]
Related MeSH Supplementary Concept(s)
- INS-17 protein, C elegans [MeSH Supplementary Concept]
- Ilp5 protein, Drosophila [MeSH Supplementary Concept]
- daf-28 protein, C elegans [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Insulin lipoatrophy (disorder) [SNOMED CT concept]
- Insulin lipohypertrophy (disorder) [SNOMED CT concept]
- Product containing insulin (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Validated automatic mappings to BTNT
- Insulin [LOINC component]
- Insulin [SMS substance]
- insulin (human) [Substance BNPC]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients